SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-21-007221
Filing Date
2021-04-20
Accepted
2021-04-20 16:45:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2021defa14a.htm DEFA14A 19965
2 notice11.jpg GRAPHIC 55113
3 notice21.jpg GRAPHIC 149156
4 notice31.jpg GRAPHIC 109053
5 notice41.jpg GRAPHIC 32679
  Complete submission text file 0001628280-21-007221.txt   476331
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38295 | Film No.: 21838465
SIC: 2836 Biological Products, (No Diagnostic Substances)